
Tyrosine Kinase Inhibitors - Induced Cutaneous Leukocytoclastic Vasculitis
Author(s) -
Diogo Alpuim Costa,
Susana Baptista de Almeida,
Pedro C. Barata,
A. Quintela,
Pedro Cabral,
Ana Afonso,
João Maia Silva
Publication year - 2018
Publication title -
gazeta médica/gazeta médica
Language(s) - Uncategorized
Resource type - Journals
eISSN - 2184-0628
pISSN - 2183-8135
DOI - 10.29315/gm.v5i1.147
Subject(s) - medicine , tyrosine kinase , leukocytoclastic vasculitis , renal cell carcinoma , cancer research , tyrosine kinase inhibitor , dermatology , vasculitis , cancer , receptor , disease
A 66-year-old patient with metastatic renal clear cell carcinoma, developed palpable purpura during systemic treatment with different tyrosine kinase inhibitors (TKI).